Nanosuspensions in drug delivery
Top Cited Papers
- 1 September 2004
- journal article
- review article
- Published by Springer Nature in Nature Reviews Drug Discovery
- Vol. 3 (9) , 785-796
- https://doi.org/10.1038/nrd1494
Abstract
A surprisingly large proportion of new drug candidates emerging from drug discovery programmes are water insoluble, and therefore poorly bioavailable, leading to abandoned development efforts. These so-called 'brickdust' candidates can now be rescued by formulating them into crystalline nanosuspensions. In the process of overcoming issues involving solubility, additional pharmacokinetic benefits of the drugs so formulated have come to be appreciated. As such, insolubility issues of the past have provoked a paradigm change, which now offers novel solutions for innovative drugs of the future.Keywords
This publication has 75 references indexed in Scilit:
- The Pharmacokinetics of Nebulized Nanocrystal Budesonide Suspension in Healthy VolunteersThe Journal of Clinical Pharmacology, 2004
- Time Course of Nodal Enhancement with CT X-Ray Nanoparticle Contrast AgentsInvestigative Radiology, 2000
- Application of Differential Scanning Calorimetry to the Estimation of Drug Purity: Various Problems and Their Solutions in Purity Analysis.CHEMICAL & PHARMACEUTICAL BULLETIN, 1997
- Nanoparticles, a drug carrier system to pass the blood-brain barrier, permit central analgesic effects of i.v. dalargin injectionsBrain Research, 1996
- The use of thermal analysis in the assessment of crystal disruptionThermochimica Acta, 1995
- Thermal analysis and calorimetric methods in the characterisation of polymorphs and solvatesThermochimica Acta, 1995
- Ultra‐Long‐Duration Local Anesthesia Produced by Injection of Lecithin‐Coated Tetracaine MicrocrystalsThe Journal of Clinical Pharmacology, 1994
- HomogenizationInternational Journal of Dairy Technology, 1992
- Similar central actions of intravenous methohexitone suspension and solution in the rabbitJournal of Pharmacy and Pharmacology, 1992
- Dissolution performance related to particle size distribution for cohpiercially available prednisolone acetate suspensionsDrug Development and Industrial Pharmacy, 1992